News

Licensing/Collaboration Opportunity: potential therapeutic for treating inflammatory diseases. Illustration of a person with inflammation in the body.

Potential Therapeutic for Treating Inflammatory Diseases

Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
More
Connect with NIH at JLABS’ event – More than SBIR: Understanding the Many Ways to Engage with NIH

Connect with NIH at JLABS’ event – More than SBIR: Understanding the Many Ways to Engage with NIH

The National Institutes of Health (NIH) has much more to offer potential collaborators than just small business innovation research (SBIR) grants. Attend this free event hosted by Johnson & Johnson’s JLABS to connect with technology transfer experts from the NIH and learn about the myriad of ways
More
Licensing/collaboration opportunity for nanobody-antiviral peptide conjugates that act as a one-two punch against viral entry to block HIV infection

Licensing/Collaboration Opportunity for Nanobody-Antiviral Peptide Conjugates for Potent HIV Entry Inhibition

The NIH National Institute of Diabetes and Digestive and Kidney Diseases is seeking a licensee or collaborator for nanobody-antiviral peptide conjugates that act as a one-two punch against viral entry to block HIV from infecting human CD4* T-cells. Potential commercial applications include: a long
More
2025 Faces of American Innovation

Bayh-Dole Coalition Recognizes Former OTT Director as a Face of American Innovation

Dr. Mark Rohrbaugh, former director of the NIH Office of Technology Transfer (OTT), has been chosen by the Bayh-Dole Coalition as one of their “Faces of American Innovation”. Mark worked at the NIH for over three decades, moving from the National Institute of Allergy and Infectious Diseases, where
More